The IPKat

AUGUST 16, 2021

Merpel does not like this form of taxi Friend of the Kat and Legal Head of Delivery for Gett in Moscow, Konstantin Voropaev has been following some developments out of Kazakhstan relating to an uptick in litigation in the taxi-app space. So the market is busy, growing and lucrative. So what is going on? Let’s start at the beginning.

Patent Troll 86

Patent Troll Marketing Marketing Patent 86

Technology & Marketing Law Blog

NOVEMBER 28, 2023

I’m pleased to share the final published version of my article, “ A SAD Scheme of Abusive Intellectual Property Litigation.” GmbH as a Possible Trademark Troll The post Now Available: the Published Version of My SAD Scheme Article appeared first on Technology & Marketing Law Blog.

Publishing 69

Publishing Intellectual Property Litigation IP 69

LexBlog IP

OCTOBER 25, 2023

collectively, “Genentech”) filed BPCIA litigation against Biogen MA Inc. On September 29, Biogen received FDA approval for its tocilizumab biosimilar, marketed as TOFIDENCE (tocilizumab-bavi). As we previously reported , in July 2023 Genentech, Inc., Hoffmann-LaRoche, Inc., and Chugai Pharmaceutical Co.,

Litigation 52

Litigation Settlement Reporting Marketing 52

Intellectual Property Law Blog

DECEMBER 15, 2023

Furthermore, the Federal Circuit found the declaration was conclusory and failed to establish that Allgenesis had any concrete plans to develop and bring to market a nintedanib treatment for pterygium. Accordingly, the Federal Circuit concluded that Allgenesis failed to show an injury in fact based on potential infringement liability.

Marketing 162

Marketing Marketing Settlement Patent 162

LexBlog IP

NOVEMBER 28, 2023

However, commonly overlooked is the fact that the underlying image or media fragment in a meme is someone’s intellectual property, and thus subject to potential legal implications if used improperly. What has been the market-effect on the underlying work? The first factor is of chief concern ordinarily.

Fair Use 52

Fair Use Intellectual Property Settlement Business 52

Traverse Legal Blog

JULY 14, 2022

Intellectual property attorneys can review the situation, prepare and send this cease and desist letter which is essentially a demand letter to the trademark infringer. If the infringer does not comply, this cease and desist letter now becomes evidence in your trademark infringement litigation. BE REALISTIC WITH YOUR GOALS.

Cease and Desist 98

Cease and Desist Trademark Litigation Intellectual Property 98

SpicyIP

SEPTEMBER 18, 2023

His predominant areas of practise are Arbitration, Commercial and Intellectual Property Laws. Furthermore, the continuous sales done by the violating party flood the market with infringing products where they are sold at a fast pace on a regular basis. He completed his B.A. Views expressed are those of the author’s alone.

Cease and Desist 115

Cease and Desist Intellectual Property Law Settlement Copyright Infringement 115

IPilogue

JANUARY 24, 2022

I was fortunate to have a patient and knowledgeable supervisor in Ben Gray with whom to discuss a number of patent issues involving litigation strategy, biologics, skinny labeling, and means by which pharmaceutical companies seek to extend their commercial monopolies.

Intellectual Property 81

Intellectual Property Branding Brands Branding 81

Biswajit Sarkar Copyright Blog

DECEMBER 19, 2023

MSMEs foster innovation by nurturing aspiring entrepreneurs, encouraging the development of innovative goods that enhance market competitiveness and fuel sustained growth. Subsidies offered for Patent and Trademark (in selected categories) registration, encouraging innovation and protecting intellectual property.

Settlement 52

Settlement Intellectual Property Registration Designs 52

LexBlog IP

FEBRUARY 5, 2024

Litigation continued for years, with Aegis raising unsuccessful counterclaims. On December 20, 2023, the parties filed a stipulated settlement agreement by which judgment would be entered in Life Spine’s favor, and Aegis would pay $8,000,000 to Life Spine by June 1, 2026.

Confidentiality 52

Confidentiality Settlement Advertising Advertising 52

Fish & Richardson Trademark & Copyright Thoughts

JANUARY 26, 2021

Fish attorney Kurt Glitzenstein spoke with The American Lawyer about Fish’s success on being the busiest patent litigation firm in the land. He discusses his goals and priorities as the Litigation Practice Group leader, where the firm is looking to expand in the next year, and more.

Litigation 40

Litigation Technology Business Patent 40

LexBlog IP

MARCH 10, 2022

The announcement states that under the settlement agreement, Alvotech has non-exclusive rights to market AVT02 in the United States starting July 1, 2023. ” The announcement further states that FDA has deferred action on Alvotech’s BLA until necessary inspections are completed. .”

Patent 52

Patent Settlement Litigation Patent Infringement 52

LexBlog IP

SEPTEMBER 15, 2022

On September 7, 2022, Genentech and Samsung filed a joint stipulation of dismissal of their BPCI patent litigation. In August 2020, the European Commission granted marketing authorization for the product, marketed as AYBINTIO (bevacizumab).

Patent 52

Patent Settlement Marketing Marketing 52

LexBlog IP

SEPTEMBER 21, 2022

A few weeks ago, we wrote about an interesting development in what had been a fairly standard Federal Trade Commission (FTC) Made in the USA (MUSA) settlement. The company and its owner filed a motion to get out of its settlement and to make the FTC change its press release, which, among other things, accused the company of “ lying.”.

Settlement 52

Settlement Government Marketing Marketing 52

LexBlog IP

JANUARY 19, 2024

As we settle into 2024, we reflect on the significant legal developments of 2023 that hold potential impact on the biologics and biosimilars market. Stay tuned to Big Molecule watch for further developments on these litigations in 2024, including developments on the IPRs related to Regeneron’s patents directed to dosing of aflibercept.

Settlement 52

Settlement Litigation Patent Reporting 52

LexBlog IP

AUGUST 30, 2022

” Well, some folks most definitely disagree when a whole settlement potentially is tanked over a press release. The perhaps unnecessarily inflammatory headline boldly touted, “FTC Sues Marketer of Personal Protective Equipment and Light Fixtures for Lying About Products Being Made in the USA and Government-Certified.”

Settlement 52

Settlement Marketing Marketing Advertising 52

LexBlog IP

MARCH 18, 2022

Indeed, one of us bloggers started at the FTC in 1998, and the first case he worked on was the agency’s litigation against R.J. ” Among other things, the settlement marked the end of the use of “all cartoon characters, including Joe Camel, in the advertising, promotion, packaging, and labeling of any tobacco product.”

Reporting 52

Reporting Advertising Advertising Settlement 52

Patently-O

OCTOBER 5, 2021

patent enforcement and litigation; c. marketing; h. Please explain whether the state of patent eligibility jurisprudence in the United States has caused you to change business strategies for protecting your intellectual property ( e.g., shifting from patents to trade secrets, or vice versa). intellectual property.

Patent 102

Patent Intellectual Property Invention Inventor 102

LexBlog IP

NOVEMBER 21, 2023

District Court for the District of New Jersey, alleging infringement of 15 patents under the BPCIA based on DRL’s submission of an aBLA for DRL_RI, a proposed biosimilar of RITUXAN (rituximab) and DRL’s provision of Notice of Commercial Marketing with respect to the same.

Settlement 52

Settlement Marketing Marketing Licensing 52

LexBlog IP

NOVEMBER 5, 2023

As we covered previously , Janssen and Amgen settled their BPCIA litigation regarding Amgen’s ustekinumab biosimilar product in May 2023. The licensure and marketing of WEZLANA could affect negotiations with CMS regarding Medicare pricing for STELARA under the Inflation Reduction Act’s Drug Price Negotiation Program.

Marketing 40

Marketing Marketing Government Litigation 40

IP Watchdog

JULY 25, 2023

On Friday, July 21, an Illinois district court ruled that a Pakistani employee of a medical device distribution company infringed on Ethicon’s trademark when he bought, marketed and sold counterfeit Ethicon devices. Ethicon is a subsidiary of Johnson & Johnson and won an $18 million default judgment.

False Advertising 40

False Advertising Settlement Contracts Advertising 40

LexBlog IP

DECEMBER 15, 2023

Furthermore, the Federal Circuit found the declaration was conclusory and failed to establish that Allgenesis had any concrete plans to develop and bring to market a nintedanib treatment for pterygium. Accordingly, the Federal Circuit concluded that Allgenesis failed to show an injury in fact based on potential infringement liability.

Marketing 52

Marketing Marketing Settlement Patent 52

LexBlog IP

FEBRUARY 27, 2024

We also noted that this theory could wreak havoc on routine employee departure litigation by creating a turf war between the court system and the NLRB. Return of Property Restriction The agreement also included a fairly standard return-of-property provision.

Confidentiality 52

Confidentiality Settlement Contracts Business 52

LexBlog IP

JANUARY 25, 2024

Janssen and Amgen settled their BPCIA litigation regarding Amgen’s ustekinumab biosimilar product in May 2023. The licensure and marketing of WEZLANA could affect negotiations with CMS regarding Medicare pricing for STELARA under the Inflation Reduction Act’s Drug Price Negotiation Program.

Marketing 52

Marketing Marketing Licensing Litigation 52

SpicyIP

JANUARY 29, 2024

Do read our summaries of the post on the DHC restraining generic competitors for Ibrunitib, Delhi High Court’s finding on opposition and examination process, and some quick tidbits on the Ram Mandir, Oppo-Nokia dispute settlement, and the Bombay High Court order on Pan cards. Read Yogesh’s post to know more about the judgment!

Music 59

Music Intellectual Property Copyright IP 59

Technology & Marketing Law Blog

DECEMBER 15, 2021

The Lenz case got a lot of press, but it ended with a confidential settlement. To my knowledge, the only litigated case that resulted in a 512(f) win was Online Policy Group v. The 512(f) plaintiff wins after 3 years of litigation and a bench trial. As a result, we’ve seen very, very few successful 512(f) enforcements.

Registration 110

Registration Fair Use Copyright Designs 110

LexBlog IP

DECEMBER 2, 2021

Shi then left Elation to start a business marketing “similar, if not identical software” using replicated source code. A settlement agreement was reached where Elation could inspect the software developed by Shi and prevent the use of any trade secrets or confidential information.

Confidentiality 52

Confidentiality Settlement Publishing Contracts 52

Patently-O

FEBRUARY 22, 2023

Stroud is General Counsel at Unified Patents – an organization often adverse to litigation-funded entities. [1] litigation finance boom of the past 20 years—as has been widely reported, private equity now undergirds huge swaths of U.S. Guest post by Jonathan Stroud. Patent assertion finance today is a multibillion-dollar business. [2]

Litigation 124

Litigation Reporting Settlement Government 124

LexBlog IP

OCTOBER 4, 2022

Cedar Lane is one of the more prolific NPEs in the patent enforcement market. Cedar Lane does not appear to take their cases much past the pleadings stage and seems to have little appetite for protracted litigation. This installment will focus on a company named Cedar Lane Technologies and their recent patent enforcement efforts.

Technology 40

Technology Patent Troll Litigation Settlement 40

LexBlog IP

AUGUST 4, 2022

A recent Federal Trade Commission (FTC) lawsuit and settlement with Opendoor Labs Inc. After purchasing homes, the company resells the homes on the open market. ” Given this manual adjustment to below market value, the FTC avoids the more challenging issue of what “market value” means to consumers.

Marketing 52

Marketing Marketing Settlement Business 52

IP Tech Blog

NOVEMBER 15, 2023

Cloudbreak Therapeutics, LLC , provides some interesting insights into patent challenge strategies, and their consequences, when a potentially infringing product is not yet on the market. An Allgenesis executive testified by declaration that the parties were unable to reach a settlement.

Patent Application 62

Patent Application Marketing Marketing Art 62

LexBlog IP

MAY 24, 2023

Texas Attorney General Ken Paxton recently announced his office has reached an $8 million settlement with Google of its lawsuit alleging deceptive radio disc jockey advertisements for the Google Pixel 4 smartphone. You might remember that we previously reported on this lawsuit when it was filed, in January 2022.

Advertising 52

Advertising Advertising Settlement Copying 52

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

Yet 2020 saw a slowdown in biosimilar activity with the lowest number of annual biosimilar approvals since 2016 and fewer product launches than 2019—as well as a decrease in district court litigation and post-grant proceedings. BPCIA Litigation. Antitrust Litigation. No earlier than July 31, 2023 per settlement.

Settlement 52

Settlement Litigation Marketing Marketing 52

LexBlog IP

JANUARY 6, 2023

As we ring in the new year, we look back at the top legal developments of 2022 that could influence the market for biologics and biosimilars. The Seventh Circuit Affirms Dismissal of the HUMIRA Antitrust Litigation. There were many interesting decisions and other developments in district court, at the Federal Circuit, and at the PTAB.

Art 40

Art Settlement Litigation Marketing 40

LexBlog IP

OCTOBER 18, 2023

27, 2023), involving a dispute between two businesses located in the same art gallery, serves as a reminder to New York art market participants to take care to avoid attorney conflicts of interest. 11] The decision provides a lesson for art market participants. Aicon Contemporary LLC , No. 650580/2023, 2023 N.Y. 33340(U) (N.Y.

Art 40

Art Confidentiality Law Artwork 40

LexBlog IP

SEPTEMBER 15, 2023

Companies using these technologies are equally at risk and should be prepared for potential litigation. HubSpot Tracking Code : Used for inbound marketing, this tool tracks visitor behavior and could potentially collect data without proper user consent. It has the potential to capture sensitive data if not configured correctly.

Cease and Desist 52

Cease and Desist Privacy Technology Litigation 52

LexBlog IP

JANUARY 26, 2022

million settlement with Fashion Nova. Accompanying this action, the FTC issued two new business guidance pieces – one for marketers and one for platforms that host reviews. The short answer is that the FTC can still get money through administrative litigation.

Cease and Desist 52

Cease and Desist Settlement Litigation Blogging 52